Enhanced induction of hepatitis C virus-specific cytotoxic T lymphocytes and protective efficacy in mice by DNA vaccination followed by adenovirus boosting in combination with the interleukin-12 expression plasmid.
about
Combined prime-boost vaccination against tick-borne encephalitis (TBE) using a recombinant vaccinia virus and a bacterial plasmid both expressing TBE virus non-structural NS1 proteinA novel adenovirus type 6 (Ad6)-based hepatitis C virus vector that overcomes preexisting anti-ad5 immunity and induces potent and broad cellular immune responses in rhesus macaques.Evidence for Protection against Chronic Hepatitis C Virus Infection in Chimpanzees by Immunization with Replicating Recombinant Vaccinia VirusPlasmid interleukin-23 (IL-23), but not plasmid IL-27, enhances the protective efficacy of a DNA vaccine against Mycobacterium tuberculosis infection.Progress on new vaccine strategies against chronic viral infectionsEnhancing Th2 immune responses against amyloid protein by a DNA prime-adenovirus boost regimen for Alzheimer's diseaseAdenovirus as vehicle for anticancer genetic immunotherapy.Construction and preparation of three recombinant adenoviruses expressing truncated NS3 and core genes of hepatitis C virus for vaccine purposesBaculovirus vectors elicit antigen-specific immune responses in miceAdjuvant activities of novel cytokines, interleukin-23 (IL-23) and IL-27, for induction of hepatitis C virus-specific cytotoxic T lymphocytes in HLA-A*0201 transgenic mice.Adenovirus-vectored vaccines.Priming with two DNA vaccines expressing hepatitis C virus NS3 protein targeting dendritic cells elicits superior heterologous protective potential in mice.T-bet is required for protection against vaccinia virus infection.Enhanced immunogenicity and antitumour effects with heterologous prime-boost regime using vaccines based on MG7-Ag mimotope of gastric cancer.Immune response induced by a different combined immunization of HBsAg vaccine.
P2860
Q24813809-546200A6-E997-498A-9860-B16841F32254Q27472927-8C320520-37A4-433E-BB14-C11BDA3DA3ABQ27487131-00A63997-F4F0-4206-9613-B893D13C6C52Q34300986-B417E1DC-AD48-418F-B439-0F8D45FEF169Q35864857-66EC243F-3BEA-40AB-ADFB-8FD267F73760Q36026890-DD9D3A70-FD71-4468-AC12-1CD0E6BFE300Q36288930-D77BBB4B-ACE4-461D-A0AB-891421E0E0DBQ36328978-43830EC2-7882-46FC-97E9-2B2C56B0A55CQ36684637-3CBF1CB9-F50C-44AA-962A-974BCB813A6DQ37349027-98E7C616-A3A7-4249-9FAB-9A2B091966FCQ37689799-30B5518C-6A18-49C4-8AB1-D6ECF0E348C9Q41087956-29DFCC32-ABF1-4EE5-AC6A-6A619A047298Q42094910-483D3923-4E5C-4349-BE4D-94109FCA1F63Q43903695-B9DD35A9-69DB-49F2-AAAF-00631F193E22Q44784875-22068AFD-ECD2-4AC0-8B2C-8E1E488B6A59
P2860
Enhanced induction of hepatitis C virus-specific cytotoxic T lymphocytes and protective efficacy in mice by DNA vaccination followed by adenovirus boosting in combination with the interleukin-12 expression plasmid.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
Enhanced induction of hepatiti ...... rleukin-12 expression plasmid.
@en
type
label
Enhanced induction of hepatiti ...... rleukin-12 expression plasmid.
@en
prefLabel
Enhanced induction of hepatiti ...... rleukin-12 expression plasmid.
@en
P2093
P1433
P1476
Enhanced induction of hepatiti ...... rleukin-12 expression plasmid.
@en
P2093
Masanori Matsui
Osamu Moriya
Toshitaka Akatsuka
P304
P356
10.1016/S0264-410X(02)00704-1
P407
P577
2003-04-01T00:00:00Z